Trade

with

Uroplasty Inc
(NASDAQ: UPI)
AdChoices
2.42
+0.11
+4.76%
After Hours :
-
-
-

Open

2.24

Previous Close

2.31

Volume (Avg)

58.65k (35.34k)

Day's Range

2.20-2.42

52Wk Range

2.19-5.40

Market Cap.

53.35M

Dividend Rate ( Yield )

-

Beta

-1.66

Shares Outstanding

22.05M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 24.58M

    • Net Income

    • -5.35M

    • Market Cap.

    • 53.35M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -23.62

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -1.66

    • Forward P/E

    • -8.06

    • Price/Sales

    • 2.06

    • Price/Book Value

    • 4.69

    • Price/Cash flow

    • -14.10

      • EBITDA

      • -4.93M

      • Return on Capital %

      • -34.11

      • Return on Equity %

      • -44.80

      • Return on Assets %

      • -34.11

      • Book Value/Share

      • 0.52

      • Shares Outstanding

      • 22.05M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 5.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.31

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 9.30

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 10.76

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 87.69

            • 64.08

            • Pre-Tax Margin

            • -23.31

            • 15.19

            • Net Profit Margin

            • -23.62

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 84.90

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -23.30

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -23.60

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 4.11

              • 2.55

              • Quick Ratio

              • 3.78

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.37

              • 1.86

              • Book Value/Share

              • 0.52

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -8.85

                • 34.01

                • P/E Ratio 5-Year High

                • -32.76

                • 224.03

                • P/E Ratio 5-Year Low

                • -3.63

                • 60.23

                • Price/Sales Ratio

                • 2.09

                • 3.17

                • Price/Book Value

                • 4.76

                • 3.20

                • Price/Cash Flow Ratio

                • -14.10

                • 18.42

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -44.80

                    (-26.70)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • -34.11

                    (-22.30)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • -44.80

                    (-26.70)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • -

                  • 34.11k

                  • Inventory Turnover

                  • -

                  • 2.77

                  • Asset Turnover

                  • 1.44

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -5.30M
                  Operating Margin
                  -21.56
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -14.10
                  Ownership

                  Institutional Ownership

                  54.53%

                  Top 10 Institutions

                  46.78%

                  Mutual Fund Ownership

                  14.20%

                  Float

                  85.00%

                  5% / Insider Ownership

                  10.59%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • MFS® New Discovery Fund

                  •  

                    1,452,126

                  • 0.00

                  • 6.59

                  • MFS® VIT New Discovery Series

                  •  

                    622,565

                  • 19.35

                  • 2.82

                  • Vanguard Total Stock Mkt Idx

                  •  

                    292,998

                  • 0.00

                  • 1.33

                  • Vanguard Extended Market Index Fund

                  •  

                    198,871

                  • 0.00

                  • 0.90

                  • Strategic Advisers® Small-Mid Cap Fund

                  •  

                    191,757

                  • 12.38

                  • 0.87

                  • Perkins Discovery Fund

                  •  

                    100,000

                  • 0.00

                  • 0.45

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    64,999

                  • 0.00

                  • 0.29

                  • Cortina Small Cap Growth Fund

                  •  

                    62,652

                  • 5.41

                  • 0.28

                  • iShares Micro-Cap

                  •  

                    61,848

                  • 1.28

                  • 0.25

                  • DFA U.S. Small Cap Portfolio

                  •  

                    12,442

                  • 0.00

                  • 0.06

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • MFS Investment Management K.K.

                  •  

                    2,557,142

                  • -1.58%

                  • 11.60

                  • Cortina Asset Management LLC

                  •  

                    1,763,618

                  • -2.35%

                  • 8.00

                  • Orbimed Advisors, LLC

                  •  

                    1,363,500

                  • 0.00%

                  • 6.18

                  • Perkins Capital Management Inc

                  •  

                    1,310,011

                  • +1.11%

                  • 5.94

                  • Manatuck Hill Partners LLC

                  •  

                    709,336

                  • 0.00%

                  • 3.22

                  • Perceptive Advisors LLC

                  •  

                    668,287

                  • +29.07%

                  • 3.03

                  • Rothschild Capital Management, LLC

                  •  

                    579,112

                  • +45.76%

                  • 2.63

                  • Vanguard Group, Inc.

                  •  

                    472,371

                  • 0.00%

                  • 2.14

                  • Dafna Capital Management LLC

                  •  

                    441,859

                  • +52.72%

                  • 2.00

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Uroplasty Inc was incorporated on January 21, 1992 as a Minnesota corporation. It is a medical device company. It develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. Its prim...moreary focus is on two products: the Urgent PC® Neuromodulation System, and Macroplastique® Implants. The Urgent PC® Neuromodulation System delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence. The Macroplastique® Implants is an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. The Company is focusing its sales and marketing efforts primarily on urol...moreogists, urogynecologists and gynecologists with significant office-based and outpatient surgery-based patient volume. The testing, manufacturing, promotion, marketing and distribution of the Company’s products in the United States, Europe and other parts of the world are subject to regulation by numerous governmental authorities, including the FDA, the European Union and other analogous agencies.lessless

                  Key People

                  Mr. Robert E. Kill

                  CEO/Director/President/Chairman of the Board

                  Mr. Brett A. Reynolds

                  CFO/Senior VP/Secretary

                  Mr. Marc M. Herregraven

                  Vice President, Divisional

                  Daniel Merz

                  Vice President, Divisional

                  David Perry

                  Vice President, Divisional

                  • Uroplasty Inc

                  • 5420 Feltl Road

                  • Minnetonka, MN 55343

                  • USA.Map

                  • Phone: +1 952 426-6140

                  • Fax: +1 952 426-6199

                  • uroplasty.com

                  Incorporated

                  1992

                  Employees

                  118

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: